Pharma Excipients
No Result
View All Result
  • Login
  • Shop
  • News
    • Specials
      • Excipients for CBD
      • Excipients & 3D Printing
      • Infographics – The overview
      • GMP-certified excipient production sites
      • The Future of TiO2
      • Excipients in the COVID-19 Vaccines
      • BASF PVP-Iodine
      • RegXcellence™
      • BASF Parenteral Excipients
    • World Days – The overview
  • Excipient basics
    • Excipient Solutions for CBD
    • Inorganic Chemicals
      • Calcium Carbonate
      • Calcium Phosphates
      • Calcium Sulfate
      • Halites
      • Metallic Oxides
      • Silica
    • Organic Chemicals
      • Actual Sugars
      • Artificial Sweeteners
      • Carbohydrates
      • Cellulose
      • Cellulose Esters
      • Cellulose Ethers
      • CMC and Croscarmellose Sodium
      • Converted Starch
      • Dried Starch
      • Microcrystalline Cellulose
      • Modified Starch
      • Starch
      • Sugars
      • Sugar Alcohols
    • Petrochemicals
      • Acrylic Polymers
      • Glycols
      • Mineral Hydrocarbons
      • Mineral Oils
      • Mineral Waxes
      • Petrolatum
      • Polyethylene Glycol (PEG)
      • Povidones
      • Propylene Glycol
      • Other Petrochemical Excipients
    • Oleochemicals
      • Fatty Alcohols
      • Glycerin
      • Mineral Stearates
      • Pharmaceutical Oils
      • Other Oleochemical Excipients
    • Proteins
  • Applications
    • 3D Printing – Drug Carrier
      • 3D Printing
      • Binder
      • Coating
      • Colour / Color
      • Coating Systems and Additives
      • Controlled Release Excipient
      • DC excipient
      • Disintegrant / Superdisintergrant
      • Drug Carrier
    • Emulsifier – Glidant
      • Emulsifier
      • Excipient for Inhalation
      • Filler
      • Film former
      • Flavour / Flavor
      • Glidant
    • Lubricant – Preservative
      • Lubricant
      • Nanotechnology
      • Orally Dissolving Technology Excipient
      • Pellet
      • Plasticizer
      • Preservative
    • Solubilizer – Viscocity Agent
      • Solubilizer
      • Speciality Excipient
      • Surfactants
      • Suspension Agent
      • Sustained Release Agent
      • Sweeteners
      • Taste Masking
      • Topical Excipient
      • Viscosity Agent
  • Sources
    • Handbook of Pharmaceutical Excipients – 9th Edition
    • EINECS Numbers
    • Excipient DMF List
    • Excipient cGMP Certification Organisations
    • FDA Inactive Ingredient List
    • FDA GRAS Substances (SCOGS) Database
    • Excipient E-Numbers
    • Whitepapers / Publications
    • Contract Development|Contract Manufacturing
  • Suppliers
    Excipient Suppliers List
    Biogrund Logo
    Biogrund
    Evonik Logo
    Evonik
    Capsugel Lonza Logo
    Capsugel Lonza
    Roquette Logo Navi
    Roquette
    ADM
    Antares Health Products Logo Navi
    Antares
    Armor Pharma
    Asahi KASEI
    Ashland
    Ashland
    BASF
    Beneo
    Captisol
    CarboHyde Logo
    CarboHyde
    Clariant Logo
    Clariant
    Croda
    DFE Pharma
    Dow Logo
    Dow
    Excipio Chemicals
    Fuji Chemical
    Gangwal
    Gattefossé
    Grace Logo Navi
    Grace
    Indovinya Logo
    Indovinya
    Ingredient Pharm
    IOI Oleo
    JRS Pharma
    KLK Oleo
    KLK Oleo
    Lactalis Logo Navi
    Lactalis
    Lipoid
    Lubrizol Life Science Health
    Lubrizol Life Science Health
    MAGNESIA
    MAGNESIA
    MEGGLE Excipients & Technology
    MEGGLE
    Mingtai Chemical Logo
    Mingtai Chemical
    Nagase Viita
    Nagase Viita
    Nomisma Logo Navi
    Nomisma
    Nordic Bioproducts
    Nordic Bioproducts
    PMC Isochem
    PMC Isochem
    PQ Logo
    PQ
    Seppic
    Seppic
    ShinEtsu
    ShinEtsu
    Sigachi
    Sigachi
    SPI Pharma Logo
    SPI Pharma
    Vikram Thermo Logo
    Vikram Thermo
    • A-B
      • ADM
      • ARMOR PHARMA
      • Ceolus™ & Celphere™
      • Ashland
      • BASF
      • Beneo – galenIQ
      • Biogrund
      • Budenheim
    • C-G
      • Captisol
      • Croda
      • Cyclolab
      • DFE Pharma
      • DuPont Pharma Solutions
      • Evonik
      • Fuji Chemical Industries
      • Gattefossé
      • Gangwal Healthcare
    • I-O
      • ingredientpharm
      • IOI Oleochemical
      • JRS Pharma
      • Kerry
      • KLK Oleo Life Science
      • Lactalis Ingredients Pharma
      • Lipoid
      • Dr. Paul Lohmann
      • Lubrizol
      • Magnesia
      • MEGGLE Excipients
      • Nagase Viita – Pharmaceutical Ingredients
      • Nordic Bioproducts Group
    • P-Z
      • Pfanstiehl
      • pharm-a-spheres
      • Pharma Line
      • PMC Isochem
      • Roquette Pharma
      • Seppic
      • Shin-Etsu
      • Sigachi Group
      • Südzucker AG
      • VIKRAM THERMO
      • Zerion Pharma
      • ZoomLab® – Your Virtual Pharma Assistant
  • Inquiries
    • Product Inquiry
    • Tailored Tableting Excipients
      • Tailored Film Coating
  • Events
    • Overview Pharmaceutical Webinars
    • Videos CPhI Frankfurt 2025
    • CPhI China 2024
    • ExciPerience – The great excipient event!
  • All4Nutra

No products in the cart.

  • Shop
  • News
    • Specials
      • Excipients for CBD
      • Excipients & 3D Printing
      • Infographics – The overview
      • GMP-certified excipient production sites
      • The Future of TiO2
      • Excipients in the COVID-19 Vaccines
      • BASF PVP-Iodine
      • RegXcellence™
      • BASF Parenteral Excipients
    • World Days – The overview
  • Excipient basics
    • Excipient Solutions for CBD
    • Inorganic Chemicals
      • Calcium Carbonate
      • Calcium Phosphates
      • Calcium Sulfate
      • Halites
      • Metallic Oxides
      • Silica
    • Organic Chemicals
      • Actual Sugars
      • Artificial Sweeteners
      • Carbohydrates
      • Cellulose
      • Cellulose Esters
      • Cellulose Ethers
      • CMC and Croscarmellose Sodium
      • Converted Starch
      • Dried Starch
      • Microcrystalline Cellulose
      • Modified Starch
      • Starch
      • Sugars
      • Sugar Alcohols
    • Petrochemicals
      • Acrylic Polymers
      • Glycols
      • Mineral Hydrocarbons
      • Mineral Oils
      • Mineral Waxes
      • Petrolatum
      • Polyethylene Glycol (PEG)
      • Povidones
      • Propylene Glycol
      • Other Petrochemical Excipients
    • Oleochemicals
      • Fatty Alcohols
      • Glycerin
      • Mineral Stearates
      • Pharmaceutical Oils
      • Other Oleochemical Excipients
    • Proteins
  • Applications
    • 3D Printing – Drug Carrier
      • 3D Printing
      • Binder
      • Coating
      • Colour / Color
      • Coating Systems and Additives
      • Controlled Release Excipient
      • DC excipient
      • Disintegrant / Superdisintergrant
      • Drug Carrier
    • Emulsifier – Glidant
      • Emulsifier
      • Excipient for Inhalation
      • Filler
      • Film former
      • Flavour / Flavor
      • Glidant
    • Lubricant – Preservative
      • Lubricant
      • Nanotechnology
      • Orally Dissolving Technology Excipient
      • Pellet
      • Plasticizer
      • Preservative
    • Solubilizer – Viscocity Agent
      • Solubilizer
      • Speciality Excipient
      • Surfactants
      • Suspension Agent
      • Sustained Release Agent
      • Sweeteners
      • Taste Masking
      • Topical Excipient
      • Viscosity Agent
  • Sources
    • Handbook of Pharmaceutical Excipients – 9th Edition
    • EINECS Numbers
    • Excipient DMF List
    • Excipient cGMP Certification Organisations
    • FDA Inactive Ingredient List
    • FDA GRAS Substances (SCOGS) Database
    • Excipient E-Numbers
    • Whitepapers / Publications
    • Contract Development|Contract Manufacturing
  • Suppliers
    Excipient Suppliers List
    Biogrund Logo
    Biogrund
    Evonik Logo
    Evonik
    Capsugel Lonza Logo
    Capsugel Lonza
    Roquette Logo Navi
    Roquette
    ADM
    Antares Health Products Logo Navi
    Antares
    Armor Pharma
    Asahi KASEI
    Ashland
    Ashland
    BASF
    Beneo
    Captisol
    CarboHyde Logo
    CarboHyde
    Clariant Logo
    Clariant
    Croda
    DFE Pharma
    Dow Logo
    Dow
    Excipio Chemicals
    Fuji Chemical
    Gangwal
    Gattefossé
    Grace Logo Navi
    Grace
    Indovinya Logo
    Indovinya
    Ingredient Pharm
    IOI Oleo
    JRS Pharma
    KLK Oleo
    KLK Oleo
    Lactalis Logo Navi
    Lactalis
    Lipoid
    Lubrizol Life Science Health
    Lubrizol Life Science Health
    MAGNESIA
    MAGNESIA
    MEGGLE Excipients & Technology
    MEGGLE
    Mingtai Chemical Logo
    Mingtai Chemical
    Nagase Viita
    Nagase Viita
    Nomisma Logo Navi
    Nomisma
    Nordic Bioproducts
    Nordic Bioproducts
    PMC Isochem
    PMC Isochem
    PQ Logo
    PQ
    Seppic
    Seppic
    ShinEtsu
    ShinEtsu
    Sigachi
    Sigachi
    SPI Pharma Logo
    SPI Pharma
    Vikram Thermo Logo
    Vikram Thermo
    • A-B
      • ADM
      • ARMOR PHARMA
      • Ceolus™ & Celphere™
      • Ashland
      • BASF
      • Beneo – galenIQ
      • Biogrund
      • Budenheim
    • C-G
      • Captisol
      • Croda
      • Cyclolab
      • DFE Pharma
      • DuPont Pharma Solutions
      • Evonik
      • Fuji Chemical Industries
      • Gattefossé
      • Gangwal Healthcare
    • I-O
      • ingredientpharm
      • IOI Oleochemical
      • JRS Pharma
      • Kerry
      • KLK Oleo Life Science
      • Lactalis Ingredients Pharma
      • Lipoid
      • Dr. Paul Lohmann
      • Lubrizol
      • Magnesia
      • MEGGLE Excipients
      • Nagase Viita – Pharmaceutical Ingredients
      • Nordic Bioproducts Group
    • P-Z
      • Pfanstiehl
      • pharm-a-spheres
      • Pharma Line
      • PMC Isochem
      • Roquette Pharma
      • Seppic
      • Shin-Etsu
      • Sigachi Group
      • Südzucker AG
      • VIKRAM THERMO
      • Zerion Pharma
      • ZoomLab® – Your Virtual Pharma Assistant
  • Inquiries
    • Product Inquiry
    • Tailored Tableting Excipients
      • Tailored Film Coating
  • Events
    • Overview Pharmaceutical Webinars
    • Videos CPhI Frankfurt 2025
    • CPhI China 2024
    • ExciPerience – The great excipient event!
  • All4Nutra
No Result
View All Result
Pharma Excipients
No Result
View All Result

Startseite » News » Regulatory landscape for inhaled biologics: Considerations and guidelines

Regulatory landscape for inhaled biologics: Considerations and guidelines

20. November 2026
Regulatory landscape for inhaled biologics

Regulatory landscape for inhaled biologics

Abstract

Despite significant scientific interest, only a small number of inhaled biologics have reached regulatory approval, reflecting the complex interplay between the inherent structural fragility of biologics during the aerosolization steps intrinsic to inhaled administration and the absence of inhalation-specific regulatory guidance. This review examines the key scientific and technical considerations that influence the stability, safety, and performance of inhaled biologics, including aggregation, chemical degradation, immunogenicity, device compatibility, and the limited availability of inhalation-qualified excipients.

Existing regulatory frameworks in the United States and Europe for biological products, inhalation products, and delivery devices provide substantial foundations for inhaled biologic development. Their application requires an integrated assessment of the final formulation–device pairing, particularly where aerosolization alters molecular integrity, biological activity, or pulmonary exposure.

This review connects these considerations with clinical experience and proposes a scope for dedicated guidance addressing quality, pulmonary safety, device performance, and clinical benefit. A survey of ongoing clinical trials reveals a growing but constrained pipeline dominated by mRNA therapeutics, protein-based agents, and viral-vectored vaccines, underscoring both progress and persistent formulation barriers. Together, these insights emphasize the urgent need for a harmonized regulatory paradigm tailored to inhaled biologics that integrates biologic-specific analytical expectations, aerosolization stress testing, and clear pathways for excipient qualification.

Introduction

FDA guidance on immunogenicity assessment for therapeutic protein products indicates that the inhalational route of administration may be associated with increased immunogenicity compared to intramuscular and intravenous (IV) routes [1]. Pulmonary delivery of different biological products has gained significant interest in the past decade owing to its non-invasive nature and potential to limit off target effects among other potential benefits [2], [3]. This interest has resulted in many inhaled biologics to be evaluated in clinical trials, however only four biological products have been listed in purple book and approved for use by inhalation route [4]. This observation, combined with the recent increased interest in developing inhaled biologic products, highlights the need to better understand the safety and toxicity testing of inhaled biologics.

Fig. 1 demonstrates some of the issues encountered with safety and toxicity testing of inhaled biologics these range from issues of immunogenicity, aggregation, long-term effects, and side effects like post-inhalation cough. For the purpose of this contribution, the term “biologic” and “biological product” are used interchangeably and the FDA definition of “Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins” is adopted [5]. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues [5].

Emerging modalities such as mRNA therapeutics, viral-vectored vaccines, recombinant enzymes, and antibody fragments underscore the need for a clearer scientific and regulatory foundation for inhaled biologics [6], [7]. These systems often exhibit pronounced sensitivity to aerosolization, where exposure to interfacial stress, shear forces, and dehydration can promote unfolding, aggregation, chemical modification, or loss of activity [8]. Such changes may affect potency, pharmacokinetics, and can influence immune recognition within the lung. These challenges are compounded by the structural and cellular features of the respiratory tract, which impose additional constraints on stability and deposition and require formulation and device strategies that account for both biologic-specific and inhalation-specific vulnerabilities [9], [10].

Despite advances in formulation science and device engineering, the regulatory landscape for inhaled biologics remains complex. Inhalation-specific guidance has historically been developed for small-molecule products, emphasizing aerodynamic performance and device robustness. Guidance for biologics focuses on structural characterization, product heterogeneity, and immunogenicity risk. When a biologic is administered via the pulmonary route, these two regulatory paradigms intersect offering a complex framework for addressing aerosol-induced structural changes, excipient justification, impurity control, or the device–product interface. These disparate guidances may contribute to uncertainty in defining critical quality attributes, appropriate analytical methods, and acceptable safety margins for biologics intended for inhalation. Regulatory agencies must evaluate whether the complete product can be manufactured consistently and used safely and effectively. For an inhaled biologic, this requires a product-specific assessment of the biologic, formulation, delivery device, and their interactions during storage, aerosolization, and patient use. Relevant evidence may include structural integrity and potency after delivery, aerosol performance, local pulmonary safety, device reliability, and usability. The studies needed to address these risks will vary with the modality, indication, dosing regimen, and device configuration.

Growing interest in inhaled biologics is also demonstrated by a few relevant reviews published during the preparation of this manuscript. Cipolla et al. discussed how existing guidance for biologics, inhalation products, and combination products can be applied to inhaled and nasal therapies, using examples involving peptides, a marketed inhaled biologic, and viral-based products [11]. Singh and Hickey examined the development of locally acting inhaled proteins in Part I; Part II addressed their characterization, including delivered-dose uniformity, aerodynamic particle size distribution, device robustness, stability, and specifications [12], [13]. Against this background, the present review examines pulmonary safety and toxicity across the product lifecycle, with particular attention to immunogenicity, aggregation, excipient and impurity exposure, and interactions between the biologic and its delivery device. A survey of 81 identified clinical trials places these risks in the context of current development activity, while the Exubera and Pulmozyme case studies examine how product design, safety evaluation, and use considerations have played out in approved products. Building on these analyses, the review also considers how aerosolization-related changes in molecular integrity and biological activity inform regulatory assessment and proposes a framework integrating quality characterization, nonclinical safety, clinical evaluation, and lifecycle management.

The current study aims to discuss some of the important considerations and regulations associated with the safety and toxicity evaluation of inhaled biologics. This work is structured as follows. In Section 2 we review some important considerations to account for and address in inhaled biological products formulations. These include discussion on the influence of immunogenicity, aggregation, excipient use, device considerations and impurities. In Section 3, the current official regulations surrounding the regulatory pathways for inhaled biologics are highlighted. Section 5 highlights products that are currently approved and in clinical trials.

Continue reading here

Ishaan Duggal, Zachary Warnken, Varsha Nair, Alan Watts, Nicholas Peppas, Hugh Smyth, Regulatory landscape for inhaled biologics: Considerations and guidelines, Advanced Drug Delivery Reviews, 2026, 115986, ISSN 0169-409X, https://doi.org/10.1016/j.addr.2026.115986.


Did you missed our webinar, watch it here for free:

Developing Reliable Capsule-Based Dry Powder Inhalers

Developing Reliable Capsule-Based Dry Powder Inhalers
Developing Reliable Capsule-Based Dry Powder Inhalers
Tags: excipientsformulation

Related Posts

Optical coherence tomography as a process analytical technology for oral film formulations
Ashland

Optical coherence tomography as a process analytical technology for oral film formulations

19. November 2026
Quantifying the impact of press deformation on compression kinematics during tableting
Armor Pharma

Quantifying the impact of press deformation on compression kinematics during tableting: An experimentally validated analytical approach

19. November 2026
Beyond Spray Drying
Continuous manufacturing

Beyond Spray Drying: Why Dynamic Process Control Matters in Modern Excipient Manufacturing

18. November 2026

Cart

Shop Search

  • Search for excipients and samples
  • Product Inquiry
  • Newsletter Registration
  • Visit the Homepage

Top Pharma-Excipient Links

  • Pharmaceutical Excipients – Some Definition
  • Inactive ingredient search for approved drug products in the USA
  • Excipient Suppliers List
  • GRAS Substances (SCOGS) Database
  • DC Excipients List
  • Homepage

About | Privacy Policy | Cookie policy | Cookie Settings | Contact | Homepage
Copyright: PharmaExcipients AG

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Shop
  • News
    • Specials
      • Excipients for CBD
      • Excipients & 3D Printing
      • Infographics – The overview
      • GMP-certified excipient production sites
      • The Future of TiO2
      • Excipients in the COVID-19 Vaccines
      • BASF PVP-Iodine
      • RegXcellence™
      • BASF Parenteral Excipients
    • World Days – The overview
  • Excipient basics
    • Excipient Solutions for CBD
    • Inorganic Chemicals
      • Calcium Carbonate
      • Calcium Phosphates
      • Calcium Sulfate
      • Halites
      • Metallic Oxides
      • Silica
    • Organic Chemicals
      • Actual Sugars
      • Artificial Sweeteners
      • Carbohydrates
      • Cellulose
      • Cellulose Esters
      • Cellulose Ethers
      • CMC and Croscarmellose Sodium
      • Converted Starch
      • Dried Starch
      • Microcrystalline Cellulose
      • Modified Starch
      • Starch
      • Sugars
      • Sugar Alcohols
    • Petrochemicals
      • Acrylic Polymers
      • Glycols
      • Mineral Hydrocarbons
      • Mineral Oils
      • Mineral Waxes
      • Petrolatum
      • Polyethylene Glycol (PEG)
      • Povidones
      • Propylene Glycol
      • Other Petrochemical Excipients
    • Oleochemicals
      • Fatty Alcohols
      • Glycerin
      • Mineral Stearates
      • Pharmaceutical Oils
      • Other Oleochemical Excipients
    • Proteins
  • Applications
    • 3D Printing – Drug Carrier
      • 3D Printing
      • Binder
      • Coating
      • Colour / Color
      • Coating Systems and Additives
      • Controlled Release Excipient
      • DC excipient
      • Disintegrant / Superdisintergrant
      • Drug Carrier
    • Emulsifier – Glidant
      • Emulsifier
      • Excipient for Inhalation
      • Filler
      • Film former
      • Flavour / Flavor
      • Glidant
    • Lubricant – Preservative
      • Lubricant
      • Nanotechnology
      • Orally Dissolving Technology Excipient
      • Pellet
      • Plasticizer
      • Preservative
    • Solubilizer – Viscocity Agent
      • Solubilizer
      • Speciality Excipient
      • Surfactants
      • Suspension Agent
      • Sustained Release Agent
      • Sweeteners
      • Taste Masking
      • Topical Excipient
      • Viscosity Agent
  • Sources
    • Handbook of Pharmaceutical Excipients – 9th Edition
    • EINECS Numbers
    • Excipient DMF List
    • Excipient cGMP Certification Organisations
    • FDA Inactive Ingredient List
    • FDA GRAS Substances (SCOGS) Database
    • Excipient E-Numbers
    • Whitepapers / Publications
    • Contract Development|Contract Manufacturing
  • Suppliers
    • A-B
      • ADM
      • ARMOR PHARMA
      • Ceolus™ & Celphere™
      • Ashland
      • BASF
      • Beneo – galenIQ
      • Biogrund
      • Budenheim
    • C-G
      • Captisol
      • Croda
      • Cyclolab
      • DFE Pharma
      • DuPont Pharma Solutions
      • Evonik
      • Fuji Chemical Industries
      • Gattefossé
      • Gangwal Healthcare
    • I-O
      • ingredientpharm
      • IOI Oleochemical
      • JRS Pharma
      • Kerry
      • KLK Oleo Life Science
      • Lactalis Ingredients Pharma
      • Lipoid
      • Dr. Paul Lohmann
      • Lubrizol
      • Magnesia
      • MEGGLE Excipients
      • Nagase Viita – Pharmaceutical Ingredients
      • Nordic Bioproducts Group
    • P-Z
      • Pfanstiehl
      • pharm-a-spheres
      • Pharma Line
      • PMC Isochem
      • Roquette Pharma
      • Seppic
      • Shin-Etsu
      • Sigachi Group
      • Südzucker AG
      • VIKRAM THERMO
      • Zerion Pharma
      • ZoomLab® – Your Virtual Pharma Assistant
  • Inquiries
    • Product Inquiry
    • Tailored Tableting Excipients
      • Tailored Film Coating
  • Events
    • Overview Pharmaceutical Webinars
    • Videos CPhI Frankfurt 2025
    • CPhI China 2024
    • ExciPerience – The great excipient event!
  • All4Nutra

About | Privacy Policy | Cookie policy | Cookie Settings | Contact | Homepage
Copyright: PharmaExcipients AG